F1PART 2Capital Fees for Pre-Application Meetings
Annotations:
Amendments (Textual)
Fee for scientific advice: application for, or variation to, EU marketing authorisationF14
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulations revoked (1.4.2016) by The Medicines (Products for Human Use) (Fees) Regulations 2016 (S.I. 2016/190), reg. 63(1) (with reg. 63(2)-(4))